The Biological Materials portfolio consists of non-patented biological materials such as:
In the majority of cases we will not file for patent protection of such materials as they can be effectively commercialized in the absence of patent protection.
Biological Materials that will be transferred to non-profits or universities would go through our Agreements Group under the standard outgoing Material Transfer Agreement (MTA).
To transfer these tools to for-profit institutions such as a biotech or pharmaceutical company, we need to have appropriate agreements in place. We may be able to make the Biological Material available for a fee as a research reagent (sold to other end users) or for internal research use only. However, there may be third-party rights involved in the material — for example:
Contact our innovation managers to assess a tool’s readiness for distribution.
For the transfer of any Biological Material, the UW Researcher will be responsible for preparing and shipping the material.